Clinical factors predicting nemolizumab response in atopic dermatitis
Clinical predictors of response to nemolizumab, an anti-IL-31 receptor A antibody, were evaluated in patients with atopic dermatitis (AD). In a retrospective study of 14 Japanese patients, longer disease duration was significantly associated with poor response to treatment. While serum IgE levels an...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-05-01
|
| Serie: | Journal of Allergy and Clinical Immunology: Global |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S277282932500058X |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|